Company profile: Avantec Vascular
1.1 - Company Overview
Company description
- Provider of coronary and peripheral vascular medical devices, including the Duraflex Coronary Stent System for vascular disease treatment, Apollo Coronary Dilatation Catheter, Captus Vascular Retrieval System for retrieving foreign objects (guide wires, coils, balloons, catheters, filters), neurovascular and peripheral coils, peripheral atherectomy, and specialty coronary/peripheral drug-eluting stents.
Products and services
- Duraflex™ Coronary Stent System: Interventional-grade coronary stent system designed for the treatment of vascular disease in coronary arteries by Avantec Vascular Corporation
- Specialty Coronary / Peripheral DES: Custom-engineered drug-eluting stents designed for coronary and peripheral vascular applications from Avantec Vascular Corporation, built to address diverse vascular treatment needs
- Captus Vascular Retrieval System: Interventional-grade device intended for use in the cardiovascular system to retrieve foreign objects such as guide wires, coils, balloons, catheters, and filters
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avantec Vascular
VasoNova
HQ: United States
Website
- Description: Provider of medical devices, including a self-guided PICC catheter; develops, manufactures, and markets these products. Based in Sunnyvale, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VasoNova company profile →
Okami Medical
HQ: United States
Website
- Description: Provider of devices for heart disease treatment, including the LOBO Vascular Occlusion System—a low-profile braided occluder enabling rapid, reliable peripheral artery vessel occlusion. Offerings include LOBO-3 (cleared for peripheral artery occlusion) and LOBO-5, LOBO-7, and LOBO-9 (FDA 510(k) cleared) for peripheral embolization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Okami Medical company profile →
Ablacon
HQ: United States
Website
- Description: Provider of AI-guided atrial fibrillation therapies, including the Ablamap System to localize and characterize functional mechanisms of AF for customized ablation; the Ablacath Mapping Catheter, used with Ablamap to identify and ablate sources outside the pulmonary veins; and the EGF Mapping System using electrographic flow mapping to detect and quantify patterns of electrical wavefront propagation in the atria.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ablacon company profile →
Renovacor
HQ: United States
Website
- Description: Provider of preclinical-stage biopharmaceutical development of transformative gene therapy-based treatments for cardiovascular disease, featuring a lead recombinant adeno-associated virus (AAV) gene therapy program for patients with dilated cardiomyopathy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renovacor company profile →
Infraredx
HQ: United States
Website
- Description: Provider of catheter-based coronary imaging devices utilizing near-infrared spectroscopy (NIRS) to identify and characterize vulnerable plaque, alongside CME-accredited webinar and educational sessions on polyvascular disease management, intravascular coronary imaging, coronary physiology, patient risk assessment, and imaging-guided interventions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Infraredx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avantec Vascular
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avantec Vascular
2.2 - Growth funds investing in similar companies to Avantec Vascular
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avantec Vascular
4.2 - Public trading comparable groups for Avantec Vascular
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →